SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0000950170-23-001817
Filing Date
2023-02-06
Accepted
2023-02-06 06:16:10
Documents
50
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A maia-20220930.htm   iXBRL 10-Q/A 3148150
2 EX-31.1 maia-ex31_1.htm EX-31.1 21496
3 EX-31.2 maia-ex31_2.htm EX-31.2 21657
4 EX-32.1 maia-ex32_1.htm EX-32.1 13125
5 EX-32.2 maia-ex32_2.htm EX-32.2 14524
  Complete submission text file 0000950170-23-001817.txt   9702956

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT maia-20220930_cal.xml EX-101.CAL 35126
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT maia-20220930_pre.xml EX-101.PRE 304171
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT maia-20220930.xsd EX-101.SCH 49209
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT maia-20220930_def.xml EX-101.DEF 167970
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT maia-20220930_lab.xml EX-101.LAB 412850
44 EXTRACTED XBRL INSTANCE DOCUMENT maia-20220930_htm.xml XML 1798386
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-41455 | Film No.: 23588309
SIC: 2834 Pharmaceutical Preparations